abstract |
The present description refers to a combination of therapeutic agents for use in the treatment of a patient suffering from cancer, wherein said combination comprises at least one polyploidy inducing agent and at least one family protein inhibitor. Bcl-2 In addition, the present description also refers to diagnostic tests useful in classifying patients for treatment with one or more therapeutic agents. |